Computational and drug target analysis of functional single nucleotide polymorphisms associated with Haemoglobin Subunit Beta (HBB) gene

Comput Biol Med. 2020 Oct:125:104018. doi: 10.1016/j.compbiomed.2020.104018. Epub 2020 Sep 25.

Abstract

There is overwhelming evidence implicating Haemoglobin Subunit Beta (HBB) protein in the onset of beta thalassaemia. In this study for the first time, we used a combined SNP informatics and computer algorithms such as Neural network, Bayesian network, and Support Vector Machine to identify deleterious non-synonymous Single Nucleotide Polymorphisms (nsSNPs) present in the HBB gene. Our findings highlight three major mutation points (R31G, W38S, and Q128P) within the HBB gene sequence that have significant statistical and computational associations with the onset of beta thalassaemia. The dynamic simulation study revealed that R31G, W38S, and Q128P elicited high structural perturbation and instability, however, the wild type protein was considerably stable. Ten compounds with therapeutic potential against HBB were also predicted by structure-based virtual screening. Interestingly, the instability caused by the mutations was reversed upon binding to a ligand. This study has been able to predict potential deleterious mutants that can be further explored in the understanding of the pathological basis of beta thalassaemia and the design of tailored inhibitors.

Keywords: Alpha thalassaemia; Beta thalassaemia; Haemoglobin subunit beta (HBB); Haemoglobinopathies; Mutation; SNP informatics; Single nucleotide polymorphism (SNPs).

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Bayes Theorem
  • Humans
  • Mutation
  • Pharmaceutical Preparations*
  • Polymorphism, Single Nucleotide / genetics
  • beta-Globins / genetics
  • beta-Thalassemia* / drug therapy
  • beta-Thalassemia* / genetics

Substances

  • Pharmaceutical Preparations
  • beta-Globins